Regulation & Licensing of Medicines - reforms in light of Seroxat
This is an invitation-only meeting of the Institute's Product Liability Forum.
Thursday 23 October 2008 17:00 to 19:00
Location
British Institute of International and Comparative Law, Charles Clore House17 Russell Square, London WC1B 5JP
Participants
Speakers include:
Professor Kent Woods,Chief Executive of the MHRA
Professor Mark Mildred, Nottingham Law School
Professor Emily Jackson, LSE
Dr Richard Goldberg, Aberdeen University
Shane Sayers, Kennedys
This is an invitation-only meeting of the Institute's Product Liability Forum.
This seminar is organized with the MHRA on the topic of pharmaceutical regulation and medicines licensing. The aim of our seminar is to look in a dispassionate way at broader issues arising from the Seroxat investigation, in particular the inadequacies of the legislative framework & ways in which this can be ameliorated. This will be a rare opportunity to discuss issues relating to the regulation of medicines with the Chief Executive of the MHRA, Professor Kent Woods.
If you would like more information on this event or joining the Institute's Product Liability Forum, please contact Dr Duncan Fairgrieve or Faria Medjouba
The seminar will run between 17.00 and 19.00, followed by a dinner at the Travellers Club and will cost £85 per person.
.jpg)
.jpg)
Moore Wilson -